Health ProductsDear Healthcare Professional Letter

Important Safety Information on Medtronic Sigma Series pacemakers- Medtronic of Canada Ltd. - For Health Professionals

· Published by Health Canada · Official notice

Details

Alert type: Dear Healthcare Professional Letter
Category: Medical Device
Audience: Healthcare Professionals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

This is duplicated text of a letter from Medtronic of Canada Ltd.
Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

 
[Text of letter begins]

Health Canada Endorsed Important Safety Information on Medtronic Sigma Series pacemakers

November 30, 2005

Subject: Important patient management information

Dear Doctor,

In accordance with Medtronic's commitment to keeping you informed about the performance of our products, we write to advise you about an issue with a specific subset of Sigma® series pacemakers that may fail due to separation of interconnect wires from the hybrid circuit. This failure mechanism may present clinically as loss of rate response, premature battery depletion, intermittent or total loss of telemetry, or no output. There have been no reported patient injuries or deaths due to this issue.

Medtronic has communicated this information to Health Canada.

Affected Devices

There are approximately 1,400 of the affected devices distributed in Canada, out of an initial implant population of 40,000 worldwide. The specific model and serial numbers of affected devices are available online at Medtronic web site.

Root Cause

Separation of redundant interconnect wires has been observed on hybrid terminal blocks. Device failure occurs only where both interconnect wires separate from a hybrid terminal block. In October 2005, we completed testing and analysis identifying the root cause of these failures and the affected population. Hybrid circuits used in this subset of devices were cleaned during manufacturing with a particular cleaning solvent that could potentially reduce the strength of the interconnect wire bond over time.

Low Probability of Occurrence

As part of the ongoing returned product analysis, Medtronic has observed 19 devices from the above population, approximately 0.05%, that have exhibited this failure mechanism. There is no provocative testing that can predict which devices may fail. Implant duration for the 19 failures ranged from 17-38 months. Our modeling predicts a failure rate from 0.17% to 0.30% over the remaining lifetime of these pacemakers.

Recommendations

Medtronic realizes that each of your patients is unique, and supports your clinical judgment in caring for them. To assist physicians in their patient care and after discussion with our physician consultants, Medtronic offers the following recommendations:

  • Medtronic does not recommend replacement of these devices prior to normal elective replacement (ERI), based on the low probability of occurrence of a serious event in this population.
  • Continue routine follow up in accordance with standard practice.
  • Advise patients to seek attention immediately if they experience return of symptoms (e.g., syncope or light headedness).
  • Determine whether device replacement is warranted on a case-by-case basis based upon consultation with patients, review of the individual patient's medical history and consideration of the relative risks of an invasive procedure.

Physician and Patient Support

Medtronic regrets the difficulties this may cause you and your patients. Medtronic will provide you with regular updates on the ongoing actual performance in our Product Performance Report, available at Medtronic web site.

Should you elect to replace a device for a specific patient, Medtronic will provide a replacement device at no cost. Medtronic's Customer Service Representative at 1-800-268-5346 is available to assist you with this or other issues.

The information in this letter will be posted on the Medtronic web site on December 5, 2005.

If you have any questions, or if Medtronic can be of further assistance, please contact your local Medtronic Representative.

Medtronic of Canada Ltd.
6733 Kitimat Road
Mississauga, Ontario L5N 1W3
Tel.: 1-800-268-5346

Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Tel: The Inspectorate Hotline 1-800-267-9675

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.

For other inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate (MHPD)
Email: MHPD_DPSC@hc-sc.gc.ca
Tel: (613) 954-6522
Fax: (613) 952-7738

Sincerely,

original signed by

Paul Devereaux
Vice President,
Cardiac Rhythm Management

MEDTRONIC OF CANADA LTD.

[Text of letter ends]
 
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime